معرفی
Luke Odell is a Full Professor at the Department of Medicinal Chemistry; Preparative Medicinal Chemistry at Uppsala University. He holds a BSc (Honours) in Forensic Science from the University of Newcastle (Australia, 2002) and a PhD in Chemistry from the same institution (2006), focusing on enzyme inhibitor synthesis. After a postdoctoral position under Professor Mats Larhed at Uppsala University, he became a Senior Lecturer in 2016 and was promoted to Full Professor in 2022.
His research focuses on molecular imaging, heterocyclic chemistry, PET chemistry, and medicinal chemistry, with a strong emphasis on drug discovery and radiopharmaceutical development. Key areas include designing PET tracers for neurodegenerative diseases, developing novel synthetic methods for bioactive compounds, and exploring enzyme inhibitors with therapeutic potential. Recent work includes studies on psilocin derivatives, IRAP inhibition for neuroprotection, and optimized radiolabeling techniques for Affibody molecules.
Dr. Odell’s publications span over 15 years, with a focus on organic synthesis, medicinal applications, and analytical techniques like MALDI-MS imaging. His team collaborates on projects addressing challenges in drug delivery, enzyme mechanisms, and molecular imaging technologies, contributing to advancements in both academic and clinical settings.
